Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05422222 |
|---|---|
| Brief Title: | Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age |
| First Submitted : | June 13, 2022 |
| First Submitted that Met QC Criteria : | June 13, 2022 |
| First Posted : | June 16, 2022 |
| Last Update Submitted that Met QC Criteria : | January 24, 2024 |
| Last Update Posted : | January 25, 2024 |